Point of view on the vaccination against COVID-19 in patients with autoimmune inflammatory rheumatic diseases

Victoria Furer; Christien Rondaan; Nancy Agmon-Levin; Sander Van Assen; Marc Bijl; Meliha Crnkic Kapetanovic; Annette De Thurah; Ulf Mueller-Ladner; Daphna Paran; Karen Schreiber; Klaus Warnatz; Nico M. Wulffraat; Ori Elkayam

doi:10.1136/rmdopen-2021-001594

Point of view on the vaccination against COVID-19 in patients with autoimmune inflammatory rheumatic diseases

Victoria Furer^*, Christien Rondaan, Nancy Agmon-Levin, Sander Van Assen, Marc Bijl, Meliha Crnkic Kapetanovic, Annette De Thurah, Ulf Mueller-Ladner, Daphna Paran, Karen Schreiber, Klaus Warnatz, Nico M. Wulffraat, Ori Elkayam

^*Kontaktforfatter for dette arbejde

Publikation: Bidrag til tidsskrift › Tidsskriftartikel › Forskning › peer review

4 Downloads (Pure)

Abstrakt

In view of the COVID-19 pandemic, there is an unmet clinical need for the guidelines on vaccination of patients with autoimmune inflammatory rheumatic diseases (AIIRD). This position paper summarises the current data on COVID-19 infection in patients with AIIRD and development of vaccines against COVID-19, discusses the aspects of efficacy and safety of vaccination, and proposes preliminary considerations on vaccination against COVID-19 in patients with AIIRD, mainly based on the expert opinion and knowledge on the use of other vaccines in this population of patients.

Originalsprog	Engelsk
Artikelnummer	e001594
Tidsskrift	RMD Open
Vol/bind	7
Udgave nummer	1
ISSN	2056-5933
DOI	https://doi.org/10.1136/rmdopen-2021-001594
Status	Udgivet - 24. feb. 2021

Bibliografisk note

Publisher Copyright:
©

Copyright:
Copyright 2021 Elsevier B.V., All rights reserved.

Dokumenter og links

10.1136/rmdopen-2021-001594Licens: CC BY-NC

Open Access VersionForlagets udgivne version, 432 KBLicens: CC BY-NC

Fingeraftryk Dyk ned i forskningsemnerne om 'Point of view on the vaccination against COVID-19 in patients with autoimmune inflammatory rheumatic diseases'. Sammen danner de et unikt fingeraftryk.

Citationsformater

Furer, V., Rondaan, C., Agmon-Levin, N., Van Assen, S., Bijl, M., Kapetanovic, M. C., De Thurah, A., Mueller-Ladner, U., Paran, D., Schreiber, K., Warnatz, K., Wulffraat, N. M., & Elkayam, O. (2021). Point of view on the vaccination against COVID-19 in patients with autoimmune inflammatory rheumatic diseases. RMD Open, 7(1), [e001594]. https://doi.org/10.1136/rmdopen-2021-001594

Furer, Victoria ; Rondaan, Christien ; Agmon-Levin, Nancy ; Van Assen, Sander ; Bijl, Marc ; Kapetanovic, Meliha Crnkic ; De Thurah, Annette ; Mueller-Ladner, Ulf ; Paran, Daphna ; Schreiber, Karen ; Warnatz, Klaus ; Wulffraat, Nico M. ; Elkayam, Ori. / Point of view on the vaccination against COVID-19 in patients with autoimmune inflammatory rheumatic diseases. I: RMD Open. 2021 ; Bind 7, Nr. 1.

@article{b914064a52ac412484bbf6881fe5adf0,

title = "Point of view on the vaccination against COVID-19 in patients with autoimmune inflammatory rheumatic diseases",

abstract = "In view of the COVID-19 pandemic, there is an unmet clinical need for the guidelines on vaccination of patients with autoimmune inflammatory rheumatic diseases (AIIRD). This position paper summarises the current data on COVID-19 infection in patients with AIIRD and development of vaccines against COVID-19, discusses the aspects of efficacy and safety of vaccination, and proposes preliminary considerations on vaccination against COVID-19 in patients with AIIRD, mainly based on the expert opinion and knowledge on the use of other vaccines in this population of patients. ",

keywords = "autoimmune diseases, COVID-19, vaccination",

author = "Victoria Furer and Christien Rondaan and Nancy Agmon-Levin and {Van Assen}, Sander and Marc Bijl and Kapetanovic, {Meliha Crnkic} and {De Thurah}, Annette and Ulf Mueller-Ladner and Daphna Paran and Karen Schreiber and Klaus Warnatz and Wulffraat, {Nico M.} and Ori Elkayam",

year = "2021",

month = feb,

day = "24",

doi = "10.1136/rmdopen-2021-001594",

language = "English",

volume = "7",

journal = "RMD Open",

issn = "2056-5933",

publisher = "BMJ Group",

number = "1",

}

Furer, V, Rondaan, C, Agmon-Levin, N, Van Assen, S, Bijl, M, Kapetanovic, MC, De Thurah, A, Mueller-Ladner, U, Paran, D, Schreiber, K, Warnatz, K, Wulffraat, NM & Elkayam, O 2021, 'Point of view on the vaccination against COVID-19 in patients with autoimmune inflammatory rheumatic diseases', RMD Open, bind 7, nr. 1, e001594. https://doi.org/10.1136/rmdopen-2021-001594

Point of view on the vaccination against COVID-19 in patients with autoimmune inflammatory rheumatic diseases. / Furer, Victoria; Rondaan, Christien; Agmon-Levin, Nancy; Van Assen, Sander; Bijl, Marc; Kapetanovic, Meliha Crnkic; De Thurah, Annette; Mueller-Ladner, Ulf; Paran, Daphna; Schreiber, Karen; Warnatz, Klaus; Wulffraat, Nico M.; Elkayam, Ori.

I: RMD Open, Bind 7, Nr. 1, e001594, 24.02.2021.

Publikation: Bidrag til tidsskrift › Tidsskriftartikel › Forskning › peer review

TY - JOUR

T1 - Point of view on the vaccination against COVID-19 in patients with autoimmune inflammatory rheumatic diseases

AU - Furer, Victoria

AU - Rondaan, Christien

AU - Agmon-Levin, Nancy

AU - Van Assen, Sander

AU - Bijl, Marc

AU - Kapetanovic, Meliha Crnkic

AU - De Thurah, Annette

AU - Mueller-Ladner, Ulf

AU - Paran, Daphna

AU - Schreiber, Karen

AU - Warnatz, Klaus

AU - Wulffraat, Nico M.

AU - Elkayam, Ori

PY - 2021/2/24

Y1 - 2021/2/24

N2 - In view of the COVID-19 pandemic, there is an unmet clinical need for the guidelines on vaccination of patients with autoimmune inflammatory rheumatic diseases (AIIRD). This position paper summarises the current data on COVID-19 infection in patients with AIIRD and development of vaccines against COVID-19, discusses the aspects of efficacy and safety of vaccination, and proposes preliminary considerations on vaccination against COVID-19 in patients with AIIRD, mainly based on the expert opinion and knowledge on the use of other vaccines in this population of patients.

AB - In view of the COVID-19 pandemic, there is an unmet clinical need for the guidelines on vaccination of patients with autoimmune inflammatory rheumatic diseases (AIIRD). This position paper summarises the current data on COVID-19 infection in patients with AIIRD and development of vaccines against COVID-19, discusses the aspects of efficacy and safety of vaccination, and proposes preliminary considerations on vaccination against COVID-19 in patients with AIIRD, mainly based on the expert opinion and knowledge on the use of other vaccines in this population of patients.

KW - autoimmune diseases

KW - COVID-19

KW - vaccination

U2 - 10.1136/rmdopen-2021-001594

DO - 10.1136/rmdopen-2021-001594

M3 - Journal article

C2 - 33627440

AN - SCOPUS:85101736250

VL - 7

JO - RMD Open

JF - RMD Open

SN - 2056-5933

IS - 1

M1 - e001594

ER -